Related Experiment Videos
Rubinstein-Taybi syndrome medical guidelines
Susan Wiley1, Susan Swayne, Jack H Rubinstein
1Children's Hospital Medical Center, Division of Developmental Disabilities, 3333 Burnet Ave., Cincinnati, Ohio 45229, USA. wiles0@chmcc.org
American Journal of Medical Genetics. Part A
|May 16, 2003
Summary
This study outlines medical guidelines for Rubinstein-Taybi Syndrome (RTS), detailing common health issues and recommending surveillance strategies for affected children and adults. Further research is essential for refining care standards.
Area of Science:
- Medical Genetics
- Pediatric Medicine
- Clinical Practice Guidelines
Background:
- Rubinstein-Taybi Syndrome (RTS) is associated with specific medical conditions occurring more frequently than in the general population.
- Existing literature and clinical experience highlight the need for structured medical guidance for RTS patients.
Purpose of the Study:
- To establish the first medical guidelines for the surveillance and intervention of Rubinstein-Taybi Syndrome in the United States.
- To provide clinicians with evidence-based recommendations for managing RTS-associated health issues.
Main Methods:
- Literature review and synthesis of clinical experience.
- Development of recommendations for medical surveillance and interventions tailored to individuals with RTS.
Main Results:
- Identification of specific medical conditions with higher prevalence in RTS patients.
- Formulation of initial medical guidelines for RTS care in the US.
Conclusions:
- The established guidelines offer a foundational approach to managing Rubinstein-Taybi Syndrome.
- Ongoing research is crucial for enhancing and refining medical care decisions and guidelines for RTS individuals.